一種背部骨折端端固定系統(tǒng)叫做Easyspine和BF+附屬合成骨替代物（包括高度生物配伍的beta三-磷酸鈣）在法國(guó)由。(Troyes)開發(fā)成功。這兩種產(chǎn)品目前都已經(jīng)獲得了美國(guó)食品藥品管理局的許可。

該公司指出：迄今為止Easyspine已經(jīng)在超過2200例手術(shù)中成功使用。產(chǎn)品獲得保護(hù)的花梗螺絲釘設(shè)計(jì)，具有整合多軸向功能，提供了平面對(duì)平面螺絲釘對(duì)螺桿的支點(diǎn)，能夠根據(jù)不同厚度螺桿進(jìn)行調(diào)節(jié)，從而產(chǎn)生不同的強(qiáng)度。這種設(shè)計(jì)方法產(chǎn)生了許多技術(shù)優(yōu)點(diǎn)，并創(chuàng)造了一個(gè)系統(tǒng)使得外科醫(yī)生手術(shù)期間能夠有更好的靈活性，只需使用傳統(tǒng)融合系統(tǒng)三分之一的器材。除此而外，所有LDR脊柱植入產(chǎn)品都是通過單個(gè)包裝、標(biāo)記、以及消毒后送到醫(yī)院。

與Troyes的LDR醫(yī)療公司保持合作，LDR脊柱(Austin, TX, USA)公司做為該公司在美國(guó)脊柱產(chǎn)品的分銷商。LDR脊柱產(chǎn)品公司的主席兼首席執(zhí)行官Steve Witelock評(píng)論說：“我們對(duì)這種產(chǎn)品在歐洲所獲得的成功感到十分高興，對(duì)外科醫(yī)生和脊柱設(shè)備分銷商對(duì)我們所有的脊柱產(chǎn)品的高度評(píng)價(jià)而感到歡欣鼓舞。”
 
Easyspine Osteosynthesis System
 
A posterior osteosynthesis system called Easyspine and the BF+ complementary synthetic bone substitute comprised of highly biocompatible beta tri-calcium phosphate were developed in France by LDR Medical (Troyes). Both have now been cleared by the U.S. Food and Drug Adminstration (FDA).

Easyspine has been successfully used in more than 2, 200 procedures to date, notes the company. Its patent-pending pedicle screw design, with integrated multi-axial capability, provides flat-on-flat screw-to-rod purchase and can vary stiffness by accommodating rods of different thickness. This design approach provides many technical advantages and creates a system that offers the surgeon better intraoperative flexibility while using only one-third the inventory levels of conventional fusion systems. In addition, all LDR spine implant products are delivered to the hospital individually packaged, labeled, and sterilized.

In partnership with LDR Medical in Troyes, LDR Spine (Austin, TX, USA) serves as a distributor of the company’s spine products in the United States. “We are excited by the success these products have experienced in Europe and are encouraged by the enthusiastic response we are getting from both surgeons and spine device distributors regarding all of our spinal product offerings,” commented Steve Whitelock, president and CEO of LDR Spine.